|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 16729483.4 (espacenet) (Federated) (European Patent Register), 20160608 | | Patent/reg. no. and date | DK/EP 3310809, 20241016 | | Publication date | 20180425 | | Priority no. and date | US 201562180905 P, 20150617 | | EP pub. no. and date |
EP 3310809 20180425 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V482489DK00 | | Inventor | SHARMA, Anant N., c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , C07K 16/18 (2006.01) , C07K 16/26 (2006.01) | | Title | ANTI-CGRP-ANTISTOFFORMULERING | | Int. application no. | US2016036407 | | Int. publication no. | WO2016205037 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
